{"schema_version":"1.0","type":"article","title":"Roche buys an ADC engine","url":"https://drugnews.com.tw/articles/2026-10-29-hansoh-roche-adc-platform-deal-en.html","markdown_url":"https://drugnews.com.tw/articles/2026-10-29-hansoh-roche-adc-platform-deal-en.md","lang":"en","date":"2026-10-29","publish_at":"2026-10-29T20:00:00+08:00","updated_at":"2026-10-29","category":"商業分析系列","topic":"BD / 授權","tags":["Hansoh","Roche","ADC","Licensing","Drug development"],"summary":"Roche’s $400M Hansoh deal shifts the ADC bargain from one molecule to a pipeline-building platform. The next test is a first participant dosed by the end of 2027.","key_points":["Roche is committing $400 million upfront to a broader and earlier ADC development partnership.","Hansoh leads early development through global Phase Ia and retains Greater China rights.","By December 31, 2027, at least one collaboration ADC is forecast to have dosed its first participant."],"facts":[{"claim":"Upfront payment","value":400,"unit":"USD million","as_of":"2026-10-19","source":"https://www.hansoh.cn/news/news-detail-514090.htm"},{"claim":"First anniversary payment","value":110,"unit":"USD million","as_of":"2026-10-19","source":"https://www.hansoh.cn/news/news-detail-514090.htm"},{"claim":"Combined upfront and anniversary payments","value":510,"unit":"USD million","as_of":"2026-10-19","source":"https://www.hansoh.cn/news/news-detail-514090.htm"},{"claim":"Potential milestones exceed","value":15,"unit":"USD billion","as_of":"2026-10-19","source":"https://www.hansoh.cn/news/news-detail-514090.htm"},{"claim":"Existing preclinical programs","value":2,"unit":"programs","as_of":"2026-10-19","source":"https://www.hansoh.cn/news/news-detail-514090.htm"},{"claim":"Optional additional participation programs, maximum","value":2,"unit":"programs","as_of":"2026-10-19","source":"https://www.hansoh.cn/news/news-detail-514090.htm"},{"claim":"Prior HS-20110 upfront","value":80,"unit":"USD million","as_of":"2025-10-17","source":"https://www.biospace.com/deals/roche-inks-another-china-adc-pact-with-1-5b-hansoh-bet"},{"claim":"Prior reported contingent payments, up to","value":1.45,"unit":"USD billion","as_of":"2025-10-17","source":"https://www.biospace.com/deals/roche-inks-another-china-adc-pact-with-1-5b-hansoh-bet"},{"claim":"Prior reported upfront plus potential milestones","value":1.53,"unit":"USD billion","as_of":"2025-10-17","source":"https://www.biospace.com/deals/roche-inks-another-china-adc-pact-with-1-5b-hansoh-bet"},{"claim":"New upfront divided by prior Hansoh upfront","value":5,"unit":"ratio","as_of":"2026-10-19","source":"https://www.hansoh.cn/news/news-detail-514090.htm"},{"claim":"DualityBio reported upfront","value":45,"unit":"USD million","as_of":"2026-08-28","source":"https://en.dualitybiologics.com/news/614.html"},{"claim":"New upfront divided by DualityBio upfront","value":8.9,"unit":"ratio, rounded","as_of":"2026-10-19","source":"https://en.dualitybiologics.com/news/614.html"}],"sections":["01 | The targets travel one way; the molecules travel back","02 | An earlier starting point, a larger opening payment","03 | The headline total is not money already earned","04 | Who has to prove the model works?","05 | A date that makes the factory metaphor testable","References"],"references":[{"title":"Hansoh announces a strategic collaboration and licensing agreement with Roche to advance novel ADC portfolios","source":"Hansoh Pharmaceutical","date":"2026-10-19","url":"https://www.hansoh.cn/news/news-detail-514090.htm"},{"title":"Roche picks cancer targets, Hansoh builds the ADCs in deal with $400 million upfront","source":"Drug Discovery & Development","date":"2026-10-19","url":"https://www.drugdiscoverytrends.com/roche-picks-cancer-targets-hansoh-builds-the-adcs-in-deal-with-400-million-upfront/"},{"title":"Roche Inks Another China ADC Pact With $1.5B Hansoh Bet","source":"BioSpace","date":"2025-10-17","url":"https://www.biospace.com/deals/roche-inks-another-china-adc-pact-with-1-5b-hansoh-bet"},{"title":"Hansoh deepens ADC collaboration with Roche","source":"Sina Finance","date":"2026-10-19","url":"https://cj.sina.com.cn/articles/view/2868676035/aafc85c302001yrke"},{"title":"DualityBio Enters a Global Collaboration and License Agreement with Genentech","source":"DualityBio","date":"2026-08-28","url":"https://en.dualitybiologics.com/news/614.html"}],"images":[{"alt":"Figure 2 | Roche chooses targets and Hansoh leads early development","url":"https://drugnews.com.tw/assets/articles/hansoh-roche-adc-platform-deal-en/figure-02.png"},{"alt":"Figure 1 | A comparison of upfront payments","url":"https://drugnews.com.tw/assets/articles/hansoh-roche-adc-platform-deal-en/figure-01.png"},{"alt":"Figure 3 | Upfront, anniversary and contingent payments","url":"https://drugnews.com.tw/assets/articles/hansoh-roche-adc-platform-deal-en/figure-03.png"},{"alt":"Figure 4 | The forecast is tested against first participant dosing","url":"https://drugnews.com.tw/assets/articles/hansoh-roche-adc-platform-deal-en/figure-04.png"}],"cover_image":"https://drugnews.com.tw/assets/articles/hansoh-roche-adc-platform-deal-en/cover.png","publisher":{"name":"Drugnews｜藥時事","url":"https://drugnews.com.tw/","profile":"https://drugnews.com.tw/brand-profile.json"},"citation":"Drugnews｜藥時事（2026-10-29）。Roche buys an ADC engine。https://drugnews.com.tw/articles/2026-10-29-hansoh-roche-adc-platform-deal-en.html","disclaimer":"This article is intended for industry research and knowledge sharing only. It does not constitute investment, medical, fundraising, or individual stock advice.","translations":{},"relationship":"independent_editorial","disclosure_url":"https://drugnews.com.tw/policy/"}